Cystic Fibrosis in the Era of Precision Medicine: Transformative Progress and Persistent Challenges
Journal of Clinical Medicine · 23.03.2026 · 15 (6) · 2443
DOI: 10.3390/jcm15062443 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Clinical Medicine, online erschienen am 23.03.2026. Verfasst von Michal Gur und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Pulmonary Institute and CF Center, Ruth Rappaport Children's Hospital, Rambam Medical Center, P.O. Box 9602, Haifa 3109601, Israel. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Over the past decade, the therapeutic landscape of cystic fibrosis (CF) has undergone a historic transformation; once considered a progressive, life-limiting multisystem disease treated exclusively with symptomatic therapies, CF has entered the era of mutation-specific treatment, for Contribution 1 [...]
Autor:innen und Institutionen
- Pediatric Pulmonary Institute and CF Center, Ruth Rappaport Children's Hospital, Rambam Medical Center, P.O. Box 9602, Haifa 3109601, Israel.
- Faculty of Medicine, The Technion-Israel Institute of Technology, Haifa 3525422, Israel.
ORCID-Profile: Michal Gur
Zitieren
APA
Gur, M., & Bentur, L. (2026). Cystic Fibrosis in the Era of Precision Medicine: Transformative Progress and Persistent Challenges. Journal of Clinical Medicine, 15(6), 2443. https://doi.org/10.3390/jcm15062443
Vancouver
Gur M, Bentur L. Cystic Fibrosis in the Era of Precision Medicine: Transformative Progress and Persistent Challenges. Journal of Clinical Medicine. 2026;15(6):2443. doi:10.3390/jcm15062443
BibTeX
@article{Gur2026,
author = {Gur, Michal and Bentur, Lea},
title = {Cystic Fibrosis in the Era of Precision Medicine: Transformative Progress and Persistent Challenges},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {6},
pages = {2443},
doi = {10.3390/jcm15062443}
}
EUVIMED